Levine Leichtman-backed Therapeutic Research Center, a provider of original, independent, and clinically referenced recommendations and education on drug therapy and medication management for pharmacists and other healthcare professionals, completed the acquisition of CriticalPoint, a provider of training programs and educational offerings, and Clinical IQ, a provider of consulting services in the areas of compounding. Financial terms were not disclosed. "We are pleased to add CriticalPoint and Clinical IQ to our industry-leading education platform, further supporting our market-leading position. The acquisition bolsters TRC's domain expertise in the area of sterile compounding and furthers our mission of empowering clinicians to improve patient care," Wes Crews, TRC CEO.